These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1144 related articles for article (PubMed ID: 28892271)

  • 1. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
    Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
    J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
    Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
    Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-drug interactions in a cohort of hospitalized elderly patients.
    Pasina L; Djade CD; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Mannucci P
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1054-60. PubMed ID: 24038765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of drug-drug interactions in patients whose substance intake was objectively identified by detection in urine.
    Schrecker J; Puet B; Hild C; Schwope DM
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):973-978. PubMed ID: 30092669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.
    Secoli SR; Figueras A; Lebrão ML; de Lima FD; Santos JL
    Drugs Aging; 2010 Sep; 27(9):759-70. PubMed ID: 20809665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential drug-drug interactions among prescriptionsfor elderly patients in primary health care.
    Gören Z; J Demirkapu M; Akpinar Acet G; Çali S; Gülçebi Idriz Oğlu M
    Turk J Med Sci; 2017 Feb; 47(1):47-54. PubMed ID: 28263519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
    Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
    Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study.
    Pasina L; Astuto S; Cortesi L; Tettamanti M; Franchi C; Marengoni A; Mannucci PM; Nobili A;
    Drugs Aging; 2016 Sep; 33(9):647-54. PubMed ID: 27581548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRN prescribing in psychiatric inpatients: potential for pharmacokinetic drug interactions.
    Davies SJ; Lennard MS; Ghahramani P; Pratt P; Robertson A; Potokar J
    J Psychopharmacol; 2007 Mar; 21(2):153-60. PubMed ID: 17329294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidity, Polytherapy, and Drug Interactions in a Neurological Context: An Example of a Multidisciplinary Approach to Promote the Rational Use of Drugs.
    Busa G; Burlina A; Damuzzo V; Chiumente M; Palozzo AC
    J Pharm Pract; 2018 Feb; 31(1):58-65. PubMed ID: 29278992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 8: Relative Receptor Binding Affinity as a Way of Understanding the Differential Pharmacology of Currently Available Antidepressants.
    Preskorn SH
    J Psychiatr Pract; 2020 Jan; 26(1):46-51. PubMed ID: 31913969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
    Lin CF; Wang CY; Bai CH
    Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between potential drug-drug interactions and mortality rate of elderly hospitalized patients.
    Rosas-Carrasco O; García-Peña C; Sánchez-García S; Vargas-Alarcón G; Gutiérrez-Robledo LM; Juárez-Cedillo T
    Rev Invest Clin; 2011; 63(6):564-73. PubMed ID: 23650669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register.
    Johnell K; Klarin I
    Drug Saf; 2007; 30(10):911-8. PubMed ID: 17867728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy, drug-drug interactions, and adverse drug reactions among systemic sclerosis patients: A cross-sectional risk factor study.
    Boukhlal S; Chouchana L; Saadi M; Casadevall M; Cohen P; Dunogue B; Murarasu A; Regent A; Mouthon L; Chaigne B
    Semin Arthritis Rheum; 2024 Aug; 67():152469. PubMed ID: 38781783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
    Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
    J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort study.
    Bennett A; Gnjidic D; Gillett M; Carroll P; Matthews S; Johnell K; Fastbom J; Hilmer S
    Drugs Aging; 2014 Mar; 31(3):225-32. PubMed ID: 24452921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge.
    Straubhaar B; Krähenbühl S; Schlienger RG
    Drug Saf; 2006; 29(1):79-90. PubMed ID: 16454536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacy in a hospitalized psychiatric population: risk estimation and damage quantification.
    Carmona-Huerta J; Castiello-de Obeso S; Ramírez-Palomino J; Duran-Gutiérrez R; Cardona-Muller D; Grover-Paez F; Fernández-Dorantes P; Medina-Dávalos R
    BMC Psychiatry; 2019 Feb; 19(1):78. PubMed ID: 30791883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-drug interactions associated with length of stay and cost of hospitalization.
    Moura CS; Acurcio FA; Belo NO
    J Pharm Pharm Sci; 2009; 12(3):266-72. PubMed ID: 20067703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.